SCHEMBL17714948

SCHEMBL17714948

c1ccc(-c2ccc(-c3cc(-c4ccccc4)nc(-c4cccc(-c5ccc6c7ccccc7n(-c7cccc(-c8ccc9c%10ccccc%10n(-c%10ccccc%10)c9c8)c7)c6c5)c4)n3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ MAPT P10636 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ NTSR1 P30989 1/20 0.39
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ AVPR1A P37288 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19774429 0.99 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL15458299 0.99 KDM4E (0.42) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL15197777 0.99 KDM4E (0.46) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL14748788 0.97 KDM4E (0.45) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL14748765 0.97 KDM4E (0.45) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL19862607 0.97 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL19774384 0.97 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL14748767 0.97 KDM4E (0.47) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL19774407 0.97 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL14748785 0.97 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-09-07 — — US disclosed
EP-3015465-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEMICAL LTD (KR) 2019-09-04 — — EP disclosed
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-02 — — US disclosed
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2019-04-09 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
EP-3015465-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2016-05-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback